Strong growth, margin pressure yet contained; pricing power tested
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 7/10
Grade A
Strong Q2 delivery on revenue and PAT met prior guidance trajectory. FY27 high-teens target appears on track (25.5% YoY). No quantitative misses on margin or volume claims versus stated.
Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Bajaj delivered 25.5% revenue and 65.9% PAT growth in Q2, with EBITDA margin maintained at 24.7% despite gross margin compression from input inflation. Management credibly articulated three long-term growth vectors (Almond Drops reinvigoration, growth portfolio, Aarohan 2.0 distribution expansion to 10%+ annual reach). However, sequential revenue decline of 2.6% and withheld next-quarter guidance signal caution on near-term demand durability post-pricing, and consumer acceptance of Q3 5% increases remains unproven.
₹332.8 Cr
Revenue · +25.5% YoY₹70.2 Cr
Reported PAT · +65.9% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 revenue 2.7% growth YoY, PAT 70 Cr, PAT margin 21%
OVERSTATEDRevenue 332.8 Cr (25.5% YoY growth), PAT 70.2 Cr (65.9% YoY), PAT margin 20.6%
EBITDA margin 25%, gross margin 59.9% in Q2
METEBITDA margin 24.7%, gross margins 59.9% Q2; consistent with opening remarks
H1 revenues up 28% to INR674 crores
METQ1 341.2 + Q2 332.8 = 674; growth aligns
Almond Drops double-digit unit volume growth
METStated 10%+ unit volume growth in Q&A; delivered 25.5% revenue growth supports strong contribution
Sequential revenue decline immaterial (2.7% stated for QoQ)
MISSRevenue -2.6% QoQ (Q1 341.2 → Q2 332.8); PAT -0.8% QoQ softens near-term momentum narrative
Earnings quality
What changed since the last call
FY27 guidance reaffirmed; no uplift
MaintainedPrior call: high-teens FY27 growth. This call: same. Q2 25.5% YoY suggests execution on track, but sequential -2.6% and withheld next-quarter visibility imply mgmt caution, not confidence to raise.
Price increase timeline crystallized
NewQ1: one calibrated increase. Q3: planned ~5% (2-3% consumer + ml-age reduction). Q2 margin compression reveals urgency; consumer response still unproven.
Distribution expansion (Aarohan) scope clarified
NeutralAarohan 2.0 is pan-India 10% YoY direct reach expansion (not phased by region). Targeting 75% index vs ~50 now. Prior call left phasing vague; this call concrete but acknowledges execution risk on revenue translation.
The Q&A
Analysts pressed hard on margin sustainability and consumer pricing acceptance. Management defended but hedged: admitted 'can't give answer' on margin guidance, said 'early data' on consumer response, declined next-quarter visibility. On distribution, Tejas Shah directly challenged whether direct reach expansion had historically driven commensurate revenue growth (citing industry data); Naveen acknowledged but argued Bajaj's portfolio diversity and pricing power mitigate the challenge. Overall tone was confident on strategy but cautious on near-term execution.
ADHO growth drivers — Vinay Shukla, PhillipCapital
AnsweredMix of all. Improvement in category + our actions. 2-3pp of growth from distribution expansion. Double-digit unit volume growth. 10%+ unit growth in ADHO. Distribution index at 50, targeting 75%.
Growth trajectory outlook — Vinay Shukla, PhillipCapital
PartialAspirations remain unchanged. High teens FY27, double-digit FY28. Can't guide next quarter. Remain confident on long-term.
Consumer pricing behavior — Avi Mehta, 360 ONE Capital
PartialEarly data but remain optimistic. Concerns on rural demand, El Niño, but government easing pain. Remain optimistic on economy.
Gross margin trajectory — Mayur Patel, 360 ONE
DodgedCan't give answer — don't know cost bucket this quarter. Buying at highest level, keeping inventory lean. Can't predict if pricing will improve margin. Difficult to predict. Committed to managing volatility at overall level.
Direct distribution outcomes — Tejas Shah, Avendus
PartialDirect cost increases cost a bit but better trade execution, range presence, stock width. At ~50, peers at ~75; opportunity. Portfolio diversity + building growth brands means different playbooks. Till 75-80%, continue focus.
Growth execution priorities — Sucrit Patil, Eyesight Fintrade
AnsweredThree vectors: (1) Almond Drops reinvigoration over 6-8 quarters, significant investment ongoing, new launches coming, just started; (2) Growth portfolio, smaller brands in large categories, excited on potential; (3) Aarohan — direct reach expansion 10% urban, >10% rural next 6 quarters.
Consumer preference shifts — Sucrit Patil, Eyesight Fintrade
PartialHair oil 91%+ penetration; demographics/preference shifts impacting <1-1.5% households. Strong premiumization trends. Lot of work on end product quality, distribution. Plenty of growth opportunity in core.
Margin outlook medium-term — Amit Purohit
PartialFocus on absolute EBITDA pool not %. In hyper-inflation, most iterate spends. In low inflation, maintain voice at lower spend. Non-direct media tightly managed. Can't predict at this point.
Stock purchases and sourcing — Makarand Basarkar, Pro Investment
AnsweredOutsourced Guwahati facility to third-party for better efficiencies towards year start. Inventory/procurement vs prior year different but. Specific details will be shared if needed.
Unit volume purity — Makarand Basarkar, Pro Investment
AnsweredUnit volume excludes free volumes. Reflection of bottles sold, not ml. Unit volume won't change with free volumes given. Reported unit volume is core underlying.
Guidance
FY27 high-teens growth (no change from prior)
HighQ2 25.5% YoY aligns with trajectory. H1 28% confirms pace. Management reaffirmed, not raised, despite strong Q2 — suggests caution on H2 demand post-pricing.
EBITDA 'near-term high' 25%, PAT 'near-term high' 21% — no explicit FY27 level guidance
LowQ2 delivered 24.7% EBITDA, 20.6% PAT. Management declined to guide FY27 margins, citing cost volatility. Pricing in Q3 will test margin recovery, but no numerical commitment.
Aarohan 2.0 capex: no specific number; pan-India 10% YoY direct reach expansion
MediumProject Aarohan Phase 1 complete; Phase 2-4 will span next phases. Infrastructure largely done; Phase 3, 4 aim to extend reach. No balance-sheet capex number disclosed.
Risks the call surfaced
Margin recovery execution
MediumGross margin compressed 180bps QoQ despite Q1 pricing. Q3 5% increase (2-3% consumer + ml-age) planned. If consumer demand softens, mgmt may be forced to moderate/withdraw pricing, deepening margin pain.
Sequential demand softness
MediumRevenue -2.6% QoQ (332.8 Cr Q2 vs ~341 Cr Q1), PAT -0.8% QoQ. Despite 25.5% YoY growth and stated 10%+ unit volume gains, sequential decline suggests demand headwinds or post-price elasticity kicking in.
Almond Drops execution risk
MediumADHO is 6-8 quarter reinvigoration program with 'significant effort and monies' invested. New campaign launched. But category was 'sluggish' for years; execution risk on whether investments convert to sustainable volume/margin lift vs. sunk cost.
Distribution expansion ROI unclear
MediumAarohan 2.0: 10% YoY direct reach expansion (now ~50 index, targeting 75). But Tejas Shah noted industry numeric distribution flat since 2019 and other companies haven't seen commensurate revenue lift. Bajaj defending strategy but no proof of incremental revenue per outlet added.
Macro uncertainty
LowManagement flagged rural demand concerns, El Niño impact, and hyperinflationary cost environment. While optimistic on government intervention and economy, uncontrolled externalities could force guidance miss or deeper pricing.
Management
Score 7/10. Direct on execution (Almond Drops strategy, Aarohan 2.0 targets), transparent on macro risks. Hedged on near-term visibility and margin recovery despite strong current-quarter results — candid about operational unknowns. Track record strong: FY27 high-teens guidance reaffirmed (not raised despite 25.5% Q2). Q1 price increase delivered margins. H1 28% growth on plan. Aarohan Phase 1 complete. One operational shift (Guwahati outsourcing) mid-cycle but justified by efficiency gains.
1 · Q3 FY27
~5% pricing implementation (2-3% consumer + ml-age). Consumer acceptance test.
2 · H2 FY27
Almond Drops new launches and 360-degree campaign; TV + digital reinvigoration ongoing.
3 · FY28
Aarohan 2.0 Phase 3, 4 rollout; 10% annual direct reach expansion (now ~50, target 75).
However, sequential revenue decline of 2.6% and withheld next-quarter guidance signal caution on near-term demand durability post-pricing, and consumer acceptance of Q3 5% increases remains unproven.
Informational and educational content only. Not investment advice.